why choose us

Clinical Trials Search

Showing 9,300 of 132,656 result(s)
A Study to Assess the Mass Balance of [14C] ABBV-903 in Healthy Male Participants Following Single Oral Dose Administration

Status: COMPLETED

Condition: Healthy Volunteer

Interventions: Solution; Oral

Date: 2023-08-10

Tobacco Cessation at FDNY

Status: NOT_YET_RECRUITING

Condition: Tobacco Use

Interventions: Participants automatically enrolled in motivational counseling.
Tailored counseling includes sharing results of Chest CT results and lung functio

Date: 2023-08-10

Anthrax AV7909 Boost Evaluation Study

Status: Completed

Condition: Anthrax

Interventions: AV7909 Anthrax Vaccine is being developed by Emergent Product Development Gaithersburg Inc. (Emergent) for PEP of disease in persons 18 through 65 yea

Date: 2023-08-10

Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS).

Status: Completed

Condition: Hidradenitis Suppurativa

Interventions: Deucravacitinib is a stable deuterium-containing compound (where deuterium is a stable, nonradioactive isotope of hydrogen) and a potent, highly selec

Date: 2023-08-10

Improving Sleep and AD Biomarkers

Status: Completed

Condition: Mild Cognitive Impairment

Interventions: Participants with MCI will receive dietary citicoline supplements.
Subjective sleep measures will be measured via the Pittsburgh Sleep Quality In

Date: 2023-08-10

Improving Care Through Improv: Promoting Mastery in the Moment

Status: Completed

Condition: Caregiver Burden

Interventions: This intervention for informal caregivers consists of training that will introduce participants to improvisational (improv) theatre and teach its core

Date: 2023-08-10

Study of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Status: Completed

Condition: Medium-chain Acyl-CoA Dehydrogenase Deficiency

Interventions: Open-label design with doses of triheptanoin up to 1.0 gm;kg triheptanoin

Date: 2023-08-10

A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat.

Status: Completed

Condition: Subcutaneous Fat

Interventions: Provided as a ready for use injectable CBL-514 solution

Date: 2023-08-10

Using VirtuaCareTM Platform for Home Programs in Acute and Chronic Shoulder Conditions: A Pilot Study

Status: NOT_YET_RECRUITING

Condition: Shoulder Disease

Interventions: Use of VirtuaCare™ system for the Home Program.

Date: 2023-08-10

Feasibility and Preliminary Efficacy of Exercise During Immunotherapy in Patients With Lung Cancer: The INHALE Trial

Status: NOT_YET_RECRUITING

Condition: Advanced Lung Cancer

Interventions: Home-based, virtually supervised, aerobic exercise intervention with trained exercise specialist.
Exercise is high intensity in an interval fashi

Date: 2023-08-10